Demand Of Self-Administered HPV Test Is Projected To Expand At A CAGR Of 6% By 2032

The group of viruses known as human papillomaviruses (HPV) has 200 or so different kinds. HPV is divided into two categories. Warts are benign tumours that are caused by low-risk HPV, but high-risk HPV can lead to a number of malignancies, including anal, penile, vulvar, and oral cancers.

Download FREE Sample Copy of This Report:

In low- and middle-income countries in 2015, cervical cancer accounted for 90% of fatalities. According to a research by the CDC (Centers for Disease Control and Prevention), in the US, over 12,000 women are diagnosed with cervical cancer each year, and 4000 of them pass away as a result. Cervical cancer screening include the cytological Pap smear test and the HPV DNA test (HPV test).

Demand Of Self-administered HPV Test Market

The demand for selfadministered HPV tests is growing as more people become aware of the virus and its associated risks. According to the Centers for Disease Control and Prevention (CDC), 79 million Americans are infected with HPV and most people will get at least one type of HPV in their lifetime. As more individuals become aware of the virus and its associated risks, they are increasingly looking for ways to test themselves for it. Selfadministered HPV tests are becoming more popular as they provide a convenient and costeffective way for individuals to screen themselves for the virus. Additionally, selfadministered tests have become more widely available as more companies have begun to offer home testing kits. This has resulted in an increased demand for selfadministered HPV tests, as more people are becoming aware of their options.

Request Customized Report as Per Your Requirements:

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size Analysis
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain Analysis

Market Segmentation

Based on the technology:

  • DNA based assays
    • Hybrid capture 2
    • Cervista HPV HR
    • Cervista HPV 16/18 tests
    • Cobas 4800 HPV
  • RNA based assays
    • APTIMA HPV Assay

Based on disease indications:

  • Cervical cancer
  • Vaginal cancer

Based on end users:

  • Clinics
  • Home-based settings
  • Healthcare centers
  • Diagnostic centers

Pre-Book This Report:

Though significant research has been done in preventing cancer, it continues to cause the mortality and morbidity among women. Self-administered HPV test helps to decline the death rate due to cervical cancer. This test is effective for women who are not accessing the routine screening. CareHPV sample collection and test kits by QIAGEN are suitable self-collected kits which can be used in low-resource settings and the samples can be stored at room temperature for about 14 days.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Leave a Reply

Your email address will not be published. Required fields are marked *